1. Main page
  2. Finance & Banking
  3. Synaptogenix

Synaptogenix

3 Decision Makers · 3 Verified Contacts

synaptogen.com
📍 New York, NYFinance & Banking🗓 Est. 2012👥 Under 10 employees

About Synaptogenix

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Leadership & Decision Makers

Contact details of 3 Synaptogenix decision makers

Robert Weinstein

Chief Financial Officer

Daniel Alkon

President & Chief Scientific Officer

Alan Tuchman

Chief Executive Officer

General Emails

General company emails, e.g. customer support lines

    admin@synaptogen.com

    Admin Team

    u003eir@synaptogen.com

    Investor Relations

    nir@synaptogen.com

    Investor Relations

Verify Synaptogenix Emails

Similar Companies like Synaptogenix

Blackstone Innovations Investments

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · Under 10 employees · $500M–$1B

HQ: New York, NY

Citi Venture Capital International

citi.com
Finance & Banking · New York, NY · Est. 2001 · 11–50 employees

HQ: New York, NY

PJT Partners

pjtpartners.com
Finance & Banking · New York, NY · Est. 2015 · 501–1000 employees

HQ: New York, NY

Jefferies

jefferies.com
Finance & Banking · New York, NY · Est. 1962 · 1001–5000 employees

HQ: New York, NY

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 30/07/2025

synaptogen.com

973-242-0005

New York, NY

Legal Name: Synaptogenix, Inc.
Employees: 1-10
Founded Date: 2012
Company Type: For Profit
Stock Symbol: OTCQX:SNPX
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: 973-242-0005
Last Investment Activity: Apr 24, 2024
Investments Activity: Apr 24, 2024 Apr 4, 2024 Apr 3, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.